Animal magic

Dechra Pharmaceuticals plc is planning to acquire Denmark-based veterinary products developer VetXX for £61.7 million in a bid to strengthen its European footprint.


Dechra Pharmaceuticals plc is planning to acquire Denmark-based veterinary products developer VetXX for £61.7 million in a bid to strengthen its European footprint.

Dechra Pharmaceuticals plc is planning to acquire Denmark-based veterinary products developer VetXX for £61.7 million in a bid to strengthen its European footprint.

The proposed acquisition will be funded by a share placing expected to raise £35 million.

Key managers of VetXX will be joining the enlarged group. If successful, the proposed acquisition will give Dechra access to a distribution network to market the enlarged product range.

Dechra Pharmaceuticals comprises six businesses spanning the group’s pharmaceuticals and services divisions and is focused on companion animal products.

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics